Topotecan Suppliers & Bulk Manufacturers
Available Forms: Oral capsules, Injection
Available Strengths: Capsule: 1 mg, 2.5 mg; Injection:4 mg/4 mL
Reference Brands: Hycamtin® (EU & US)
Category: Oncology Cancer Care
Topotecan is available in Oral capsules, Injection and strengths such as Capsule: 1 mg, 2.5 mg; Injection:4 mg/4 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Topotecan is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Topotecan can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Topotecan, marketed under the brand Hycamtin®, is a vital chemotherapy agent used to treat cancers such as ovarian, small cell lung cancer, and cervical cancer. Available in IV injection and oral capsule forms, with strengths like 4 mg/4 mL (injection) and 1 mg (oral capsules), Topotecan works by inhibiting topoisomerase I, preventing cancer cells from replicating. Sourced by B2B pharmaceutical suppliers, Topotecan ensures GMP-compliant manufacturing and a reliable supply to oncology centers in the US and EU, providing effective treatment for aggressive cancers with competitive pricing.
Frequently Asked Questions
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View Details
Durvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View Details
Sunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers